Trial intelligence / Profile preview

Multimodal Preemptive Analgesia in Pediatric Abdominal Cancer Surgeries

NCT03580980Completed

Sponsor
National Cancer Institute
Start
Apr 2015
Primary completion
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of acetaminophen, ketamine and ketorolac in postoperative pain (3 arms), sponsored by National Cancer Institute. Primary endpoint: Total morphine consumption at 24 hours. Started Apr 2015; status: completed.

02

Drugs

acetaminophenketamineketorolac
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03580980.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03580980.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call